Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices
- PMID: 30380015
- DOI: 10.1093/europace/euy237
Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices
Abstract
Aims: Left atrial appendage closure (LAAC) is increasingly used as an alternative to oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF) patients. Feasibility and safety of left atrial (LA) catheter ablation (CA) in patients with previously implanted LAAC devices have not been well studied. We report on the feasibility, safety, and efficacy of LA CA in the presence of a previously implanted LAAC device.
Methods and results: In this prospective cohort study consecutive patients that underwent LA CA with a previously implanted Watchman device were included. Periprocedural characteristics and long-term clinical follow-up were evaluated. Twenty-three LA CA procedures were performed in 19/162 AF patients with previously implanted Watchman devices [47% male, age 63.9 ± 6.2 years, CHA2DS2-VASc 4.0 (3.0-5.0); HASBLED 3.0 (2.0-4.0); 63% paroxysmal]. Left atrial CA was performed with irrigated radiofrequency (RF; n = 20, 87%) or phased RF (n = 3, 13%) in a mean of 18 months after LAAC implantation (range 4-80 months). Targets of CA consisted of pulmonary vein isolation (n = 19, 83%), superior vena cava isolation (n = 13, 57%), and additional linear lesions (n = 8, 35%). Procedures were carried out under vitamin K antagonist (VKA; n = 6, 26%), non-VKA OAC (NOAC; n = 8, 35%), or single antiplatelet therapy alone (n = 9, 39%). Left atrial CA was successful without any signs of interference from the device. Procedure-related complications were not observed. During a mean follow-up of 28 months, 11 patients (58%) had AF recurrence.
Conclusion: Left atrial CA after LAAC appears to be feasible, effective, and safe in this single centre cohort. Previously implanted Watchman device should not be a reason to relinquish CA in symptomatic AF patients, even in patients on single antiplatelet therapy alone.
Keywords: Atrial fibrillation; Catheter ablation; Left atrial appendage; Left atrial appendage closure; Stroke prevention.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.Heart Rhythm. 2015 Jul;12(7):1524-31. doi: 10.1016/j.hrthm.2015.03.011. Epub 2015 Mar 10. Heart Rhythm. 2015. PMID: 25769512
-
Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.Europace. 2015 Oct;17(10):1533-40. doi: 10.1093/europace/euv070. Epub 2015 May 1. Europace. 2015. PMID: 25935163
-
Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.JACC Cardiovasc Interv. 2019 Jun 10;12(11):1055-1063. doi: 10.1016/j.jcin.2019.04.004. JACC Cardiovasc Interv. 2019. PMID: 31171282
-
Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.BMC Cardiovasc Disord. 2020 Feb 12;20(1):78. doi: 10.1186/s12872-020-01349-9. BMC Cardiovasc Disord. 2020. PMID: 32050904 Free PMC article.
-
Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis.BMC Cardiovasc Disord. 2019 Jun 10;19(1):138. doi: 10.1186/s12872-019-1123-2. BMC Cardiovasc Disord. 2019. PMID: 31182014 Free PMC article.
Cited by
-
Safety and Efficacy of Left Atrial Catheter Ablation in Patients with Left Atrial Appendage Occlusion Devices.J Clin Med. 2022 May 31;11(11):3110. doi: 10.3390/jcm11113110. J Clin Med. 2022. PMID: 35683497 Free PMC article.
-
Combination of ablation and left atrial appendage closure as "One-stop" procedure in the treatment of atrial fibrillation: Current status and future perspective.Pacing Clin Electrophysiol. 2021 Jul;44(7):1259-1266. doi: 10.1111/pace.14201. Epub 2021 Mar 9. Pacing Clin Electrophysiol. 2021. PMID: 33629763 Free PMC article. Review.
-
Catheter ablation alone versus catheter ablation with combined percutaneous left atrial appendage closure for atrial fibrillation: a systematic review and meta-analysis.J Interv Card Electrophysiol. 2024 Dec;67(9):2147-2158. doi: 10.1007/s10840-024-01915-7. Epub 2024 Sep 4. J Interv Card Electrophysiol. 2024. PMID: 39230634
-
Long-term outcomes of left atrial appendage closure with or without concomitant pulmonary vein isolation:a propensity score matching analysis based on CLACBAC study.BMC Cardiovasc Disord. 2024 Feb 3;24(1):85. doi: 10.1186/s12872-024-03725-1. BMC Cardiovasc Disord. 2024. PMID: 38310248 Free PMC article.
-
Hospital outcomes of patients receiving catheter ablation of atrial fibrillation, left atrial appendage closure, or both.J Interv Card Electrophysiol. 2023 Jun;66(4):913-921. doi: 10.1007/s10840-022-01370-2. Epub 2022 Sep 17. J Interv Card Electrophysiol. 2023. PMID: 36114936
MeSH terms
LinkOut - more resources
Full Text Sources
Medical